Next 10 |
2024-04-23 10:29:06 ET More on Edgewise Therapeutics Edgewise Therapeutics: Behind The Massive Rally Krystal Biotech, Candel, Edgewise gain after FDA fast track tags Seeking Alpha’s Quant Rating on Edgewise Therapeutics Historical earnings data for Edg...
2024-04-23 09:30:00 ET Summary Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. In the quarter ended March 31, 2024, Baron Health Care Fund advanced 8.92% compared wi...
2024-04-22 12:53:43 ET More on S&P 500 Index: Fed's Commercial Banking Report Shows Economic Headwinds, But Deposit Growth Bucks Trend S&P 500: Capitulation? Week Starting 22nd April (Technical Analysis) Powell Playing Games: 'Sell In May' Is Now 'Sell Before...
2024-04-22 12:03:46 ET More on GSK, Sanofi, etc. GSK Trades At Low Price Multiples, But Its Pipeline Needs To Improve Sanofi: My Top Pick In Big Pharma Sanofi (SNY) Barclays 26th Annual Global Healthcare Conference (Transcript) GSK shingles vaccine shown 82% ...
2024-04-22 11:04:15 ET More on S&P 500 Index: Fed's Commercial Banking Report Shows Economic Headwinds, But Deposit Growth Bucks Trend S&P 500: Capitulation? Week Starting 22nd April (Technical Analysis) Powell Playing Games: 'Sell In May' Is Now 'Sell Before...
2024-04-22 10:14:17 ET More on AbbVie, Pfizer, etc. Unveiling Pfizer's Potent Cocktail: Key Drivers Of Free Cash Flow Growth AbbVie Q1 Earnings Preview: No Repeat Of Last Year's Q1 Disappointment AbbVie: Through Humira's Crisis Towards Solid Growth AbbVie suc...
EMBLAVEO ® is the first β-lactam/β-lactamase inhibitor antibiotic combination approved in the European Union for treating serious infections in adult patients caused by multidrug-resistant Gram-negative bacteria, including metallo-β-lactamase-producing bacteria ...
2024-04-22 08:00:00 ET Summary 2023 was up 24%. 3 months down in 2024 and the S&P 500 is already up 6%, down from the plus 10% they were at. We are missing a few hundred in dividend income in March of this year, we normally would have had, but will be added to the April divide...
2024-04-21 20:04:07 ET More on Eli Lilly, Novo Nordisk, etc. Read the full article on Seeking Alpha For further details see: 13 new obesity drugs could hit the market by 2029 amid surging demand
2024-04-21 14:42:04 ET More on the markets SPY: Higher For Longer Could Be Good News S&P 500: Positive Outlook, I'm Modifying My Hedge SPY: Resurgent Inflation, Soaring Yields, Geopolitical Turmoil - 1970s All Over Again? Wall Street's April pullback inte...
News, Short Squeeze, Breakout and More Instantly...
Moderna Inc. (NASDAQ:MRNA) is set to clash with Pfizer Inc. (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) i...
EMBLAVEO ® is the first β-lactam/β-lactamase inhibitor antibiotic combination approved in the European Union for treating serious infections in adult patients caused by multidrug-resistant Gram-negative bacteria, including metallo-β-lactamase-producing bacteria ...
A look at the top 10 most actives in Canada Troilus Gold Corp (TLG) rose 1.4% to $0.7 on volume of 19,342,615 shares Royal Bank of Canada (RY) fell 0.1% to $133.2 on volume of 3,932,729 shares Desjardins RI Developed ex-USA ex-Canada - Low CO2 Index ETF (DRMD) rose 0.0% to $26.72 on volum...